北美旅行疫苗市场预测至 2028 年 – COVID-19 影响和区域分析 – 按产品（甲型肝炎、乙型肝炎、脑膜炎球菌疫苗等）和应用（国内旅行和出境旅行）
No. of Pages: 120 | Report Code: BMIRE00025499 | Category: Life Sciences
No. of Pages: 120 | Report Code: BMIRE00025499 | Category: Life Sciences
出行和旅游已成为不可或缺的一部分人类生活方式的一部分。旅行和旅游不仅改变了人们的日常生活，而且还提供了探索不同文化、传统、唯灵论、乡村和民族旅游、健康和健康假期等世界各地的机会。出国旅行需要免疫接种作为安全和预防措施，以避免传播感染。各个国家都有保护其公民免受旅行相关感染的政策。上述估计表明，未来几年旅行和旅游业将会增加。此外，经济危机和对更好就业机会的需求促进了该地区旅行和旅游业的增长。因此，旅行和旅游的增加推动了对旅行疫苗的需求。此外，经济危机和对更好就业机会的需求也促进了全球旅行和旅游业的增长。因此，旅行和旅游的增加推动了对旅行疫苗的需求。
借助新功能和技术，供应商可以吸引新客户并扩大其在新兴市场的足迹市场。这一因素可能会推动北美旅行疫苗市场的发展。北美旅行疫苗市场预计在预测期内将以良好的复合年增长率增长。
北美旅行疫苗市场细分
北美旅行疫苗市场按产品、应用和国家/地区细分。北美旅行疫苗市场按产品分为甲型肝炎、乙型肝炎、脑膜炎球菌疫苗等。 2021年，其他细分市场占据最大市场份额。按应用划分，北美旅行疫苗市场分为国内旅行和出境旅行。 2021年，出境游细分市场占据最大份额。根据国家/地区，北美旅行疫苗市场分为美国、加拿大和墨西哥。 2021 年，美国占据最大的市场份额。
雅培； Dynavax 技术；紧急生物解决方案公司；葛兰素史克公司；默克公司有限公司；诺华公司；辉瑞公司；赛诺菲；和 Valneva SE 是该地区旅行疫苗市场的领先公司之一。
Strategic insights for North America Travel Vaccines involve closely monitoring industry trends, consumer behaviours, and competitor actions to identify opportunities for growth. By leveraging data analytics, businesses can anticipate market shifts and make informed decisions that align with evolving customer needs. Understanding these dynamics helps companies adjust their strategies proactively, enhance customer engagement, and strengthen their competitive edge. Building strong relationships with stakeholders and staying agile in response to changes ensures long-term success in any market.
| Report Attribute | Details |
|---|---|
| Market size in 2021 | US$ 1,276.32 Million |
| Market Size by 2028 | US$ 2,503.59 Million |
| Global CAGR (2021 - 2028) | 10.1% |
| Historical Data | 2019-2020 |
| Forecast period | 2022-2028 |
| Segments Covered |
By 产品
|
| Regions and Countries Covered | 北美
|
| Market leaders and key company profiles |
The regional scope of North America Travel Vaccines refers to the geographical area in which a business operates and competes. Understanding regional nuances, such as local consumer preferences, economic conditions, and regulatory environments, is crucial for tailoring strategies to specific markets. Businesses can expand their reach by identifying underserved regions or adapting their offerings to meet regional demands. A clear regional focus allows for more effective resource allocation, targeted marketing, and better positioning against local competitors, ultimately driving growth in those specific areas.
The North America Travel Vaccines Market is valued at US$ 1,276.32 Million in 2021, it is projected to reach US$ 2,503.59 Million by 2028.
As per our report North America Travel Vaccines Market, the market size is valued at US$ 1,276.32 Million in 2021, projecting it to reach US$ 2,503.59 Million by 2028. This translates to a CAGR of approximately 10.1% during the forecast period.
The North America Travel Vaccines Market report typically cover these key segments-
The historic period, base year, and forecast period can vary slightly depending on the specific market research report. However, for the North America Travel Vaccines Market report:
The North America Travel Vaccines Market is populated by several key players, each contributing to its growth and innovation. Some of the major players include:
The North America Travel Vaccines Market report is valuable for diverse stakeholders, including:
Essentially, anyone involved in or considering involvement in the North America Travel Vaccines Market value chain can benefit from the information contained in a comprehensive market report.
Office No. 1011, First floor, Farena Corporate Park, Magarpatta-Mundhwa road, Pune - 411028, Maharashtra, India
US:+16467917070
sales@businessmarketinsights.com
Get Free Sample For North America Travel Vaccines Market
